Trial · NCT02924285
Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease
NCT02924285, Phase 3, Completed, University of Leipzig
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease. Trials, record NCT02924285. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02924285
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease
- NCT number
- NCT02924285
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 80 participants, actual
- Lead sponsor
- University of Leipzig
- Conditions
- Heart Diseases, Cardiomyopathies, Ventricular Premature Complexes
- Interventions
- Procedure (Radiofrequency catheter ablation), Amiodarone
- First posted
- 2016-10-05
- Last updated
- 2021-07-22
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Verification of superiority of catheter ablation over amiodarone for treatment of PVCs in patients with structural heart disease | Baseline and after 6 weeks | difference of the PVC burden in a 24 h Holter registration after 6 weeks and at baseline expressed as the amount of the baseline value ΔVES\_r = (VES\_6 - VES\_0) / VES\_0 |
| Secondary | Change in quality of life (QoL) score according EQ-5D questionnaire | Baseline, after 6 weeks and 12 months | |
| Secondary | Change in 6 minute walking distance | Baseline, after 6 weeks and 12 months | |
| Secondary | Change in left ventricular ejection fraction (LVEF) | Baseline, after 6 weeks and 12 months | |
| Secondary | Change in serum NT-proBNP level | Baseline, after 6 weeks and 12 months | |
| Secondary | Change in New York Heart Association (NYHA) functional class | Baseline, after 6 weeks and 12 months | |
| Secondary | Occurrence of cardiovascular related hospitalization | after 6 weeks and 12 months | |
| Secondary | Occurrence of drug adverse effects | after 6 weeks and 12 months | |
| Secondary | Occurrence of procedure related complications | after 6 weeks and 12 months | |
| Secondary | Difference of the PVC burden in a 24 h Holter registration after 12 months and at baseline expressed as the amount of the baseline value | Baseline and after 12 months |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02924285
GET https://conductscience.org/api/trials/v1/NCT02924285/registered